Mohammad-Reza Rezvany

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

Jeanette Lundin, Anna Porwit‐MacDonald, Eva Rossmann et al. · Leukemia · 2004 · 118 citations

Hematological Malignancy, Lymphoid Neoplasia, Subcutaneous Alemtuzumab +11

Oligoclonal TCRBV Gene Usage in B-Cell Chronic Lymphocytic Leukemia: Major Perturbations Are Preferentially Seen Within the CD4 T-Cell Subset

Mohammad-Reza Rezvany, Mahmood Jeddi‐Tehrani, Anders Österborg et al. · Blood · 1999 · 87 citations

Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell–tumour hybrids in B-CLL

Parviz Kokhaei, Mohammad-Reza Rezvany, Lena Virving et al. · Leukemia · 2003 · 82 citations

Cancer Immunosurveillance, Dendritic Cell–tumour Hybrids, Immunology +11

Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia

Mohammad-Reza Rezvany, Mahmood Jeddi‐Tehrani, Hans Wigzell et al. · Blood · 2003 · 73 citations · Full text

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

Eva Mikaelsson, Amir Hossein Daneshmanesh, Alfred Lüppert et al. · Blood · 2005 · 64 citations · Full text